site stats

Elaprase monograph

WebPediatric drug monographs for elaprase provide an overview of the drug product, therapeutic uses, key development issues, regulatory information, and therapeutic classifications on ScriptSave WellRx.

A Study of Elaprase in Children and Adults With Hunter …

WebFeb 16, 2024 · The information in a product information document has been written by the pharmaceutical company responsible for the medicine and has been approved by the TGA. It provides objective information about the quality, safety and effectiveness of the medicine, as demonstrated in the data provided to the TGA by the pharmaceutical company. WebMay 16, 2007 · Idursulfase is a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal iduronate sulfate residues from the glycosaminoglycans dermatan sulfate and heparan sulfate in the … tartar busters https://roschi.net

A Study of ELAPRASE in Treatment-naïve Participants With …

WebSep 27, 2024 · The main aim of this study is to learn more about the safety profile of Elaprase in Indian children and adults with hunter syndrome. Participants will receive Elaprase once per week over a 3-hour period which can be reduced to 1 hour as determined by the study doctor. Participants will need to visit the clinic weekly during the … WebIndications and Usage ELAPRASE ® (Idursulfase) is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking capacity in patients 5 years and older. In patients 16 months to 5 years of age, no data are available to demonstrate improvement in disease-related symptoms or long … WebTotal mL of ELAPRASE . Total mL of ELAPRASE ÷ 3 mL per vial = Total number of vials . Round up to the next whole vial to determine the total number of vials needed. Remove the required number of vials from the refrigerator to allow them to reach room temperature. b. Before withdrawing the ELAPRASE solution from the vial, ly visualinspect each ... 高尺スカイドーム x1

DailyMed - ELAPRASE- idursulfase solution, concentrate

Category:Elaprase European Medicines Agency

Tags:Elaprase monograph

Elaprase monograph

Idursulfase - Wikipedia

WebOct 21, 2024 · Prepare and use ELAPRASE according to the following steps using aseptic technique: Determine the total volume of ELAPRASE to be administered and the number of vials needed based on the patient's weight and the recommended dose of 0.5 mg/kg. Patient's weight (kg) × 0.5 mg per kg of ELAPRASE ÷ 2 mg per mL =. Total mL of … WebEach vial of Elaprase is intended for single use only and contains 6 mg of idursulfase in 3 ml of solution. Elaprase is for intravenous infusion and must be diluted in sodium chloride 9 mg/ml (0.9%) solution for infusion prior to use. It is recommended to deliver the total volume of infusion using a 0.2 µm in line filter.

Elaprase monograph

Did you know?

WebPediatric drug monographs for elaprase provide an overview of the product, therapeutic uses, key development issues, regulatory information on ScriptSave WellRx. WebELAPRASE has been shown to improve walking capacity in patients 5 years and older.In patients 16 months to 5 years of age, no data are available to demonstrate improvement …

WebFeb 11, 2024 · ELAPRASE® Product Monograph Page 1 of 31. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ELAPRASE® idursulfase for … WebJan 11, 2024 · What is Elaprase? Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter's syndrome, also called mucopolysaccharidosis (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis). Idursulfase contains a natural enzyme that some people lack because of a genetic disorder. Elaprase helps …

WebELAPRASE is a prescription medicine for patients with Hunter syndrome. ELAPRASE has been shown to improve walking ability in patients 5 yrs and older. In patients 16 months to 5 years old, ELAPRASE did not show improvement in disease-related symptoms or long-term clinical results; however, treatment with ELAPRASE has reduced spleen size ... WebELAPRASE. IDURSULFASE (EYE dur SUL fase) is used to replace an enzyme that is missing in patients with Hunter syndrome. It is not a cure. ELAPRASE Monographs. …

WebELAPRASE is a prescription medicine for patients with Hunter syndrome. ELAPRASE has been shown to improve walking ability in patients 5 yrs and older. In patients 16 months …

WebOct 1, 2024 · Prepare and use Elaprase according to the following steps using aseptic technique: Determine the total volume of Elaprase to be administered and the number of … tartar companyWebELAPRASE is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has … tartar danceWebProduct Monograph. CUVITRU® Normal Immunoglobulin (Human) Product Monograph. DEXILANT ® dexlansoprazole. Product Monograph: ELAPRASE ® idursulfase for … tartar bleeding gumsWebBlack Box Warnings. Anaphylactoid reactions, which may be life threatening, have been observed in some patients during idursulfase infusions. Anaphylaxis, presenting as respiratory distress, hypoxia, hypotension, urticaria and/or angioedema of throat or tongue have been reported to occur during and after infusions, regardless of duration of the ... tartar bowWebMonographie MDd’ELAPRASE Page 1 de 34. MONOGRAPHIE DE PRODUIT . INCLUANT LES RENSEIGNEMENTS SUR LE MÉDICAMENT POUR LE PATIENT . Pr ELAPRASEMD. idursulfase pour injec tion . Formule concentrée de 2 mg/mL à diluer en solution pour perfusion intraveineuse . Enzymothérapie de remplacement . tartar busterWebELAPRASE is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line. In conjunction with the market approval of ELAPRASE, Shire Human Genetic Therapies (the Shire business unit focused on genetic diseases) has introduced a new product support center called … tartard 25/108WebELAPRASE ® (Idursulfase) is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking … 高 尾山 グルメ